RADNOR, Pa., July 5, 2016 /PRNewswire/ -- VWR (NASDAQ: VWR), the leading global independent provider of product and service solutions to laboratory and production customers, announced today that it has acquired PAW BioScience Products, Inc., a manufacturer and distributor of sanitary fluid handling products used in the biotechnology, biopharmaceutical and diagnostic industries. PAW's primary business operations focuses on single-use connectors and components, custom design and assembly and product distribution supporting the cell culture and purification processes.
"Complementing our existing single-use product and service offering, PAW will be a great addition to the VWR team," said Manuel Brocke-Benz, President and CEO of VWR. "VWR bioprocessing customers will now have access to an even broader range of innovative products in our single-use portfolio, including the PAW SterilEnz® and OmniTop Sample Tubes® lines."
Founded in 2000 and based in Eatontown, New Jersey, PAW serves customers across the U.S.
Financial details of this acquisition remain confidential.
VWR (NASDAQ: VWR), headquartered in Radnor, Pennsylvania, is the leading global independent provider of product and service solutions to laboratory and production customers. With sales in excess of $4.3 billion in 2015, VWR enables science for customers in the pharmaceutical, biotechnology, industrial, education, government and healthcare industries. With more than 160 years of experience, VWR has cultivated a value proposition delivering product choice, operational excellence and differentiated services to improve our customers' productivity from research to production. VWR's differentiated services provide innovative, flexible and customized solutions from scientific research services to custom-manufactured chemical blends. Our dedicated team of more than 9,300 associates is focused on supporting scientists, medical professionals and production engineers to achieve their goals.
For more information on VWR, please visit www.vwr.com.
Director, Corporate Communications
Phone: (484) 885-9338
John Sweeney, CFA
VP, Investor Relations
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/vwr-acquires-paw-bioscience-products-inc-300293543.html